4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Extrawell Pharmaceutical Holdings Limited (0858) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Quarry Bay, Hong Kong with about 158 employees. Its market capitalization is roughly HK$232 million. In the fiscal year ended 2025-03-31, 0858 reported HK$55M in revenue and HK$223M in net income.
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Manufacturing and Trading segments.
Interactive charts & full statements → Open the 0858 valuation workbench →
| Income statement | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue | HK$55M | HK$59M | HK$73M | HK$74M |
| Gross Profit | HK$22M | HK$29M | HK$31M | HK$38M |
| Operating Income (EBIT) | (HK$9M) | (HK$6M) | (HK$12M) | (HK$12M) |
| Net Income | HK$223M | (HK$163M) | HK$129M | HK$131M |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Assets | HK$1.5B | HK$1.3B | HK$1.4B | HK$1.3B |
| Total Liabilities | HK$192M | HK$175M | HK$163M | HK$152M |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0858 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms